Efficacy of Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia (Protocol No. ABP-19002)

Clinical Trial Title

An Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Repeat Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia (Protocol No. ABP-19002)

National Clinical Trial Number:

NCT04849988

Contact Information

Clinical Trial Protocol Description:

The purpose of this study is to determine whether an investigational drug, ABP-450 (prabotulinumtoxinA) is safe and effective in treating cervical dystonia (CD).

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Be between the ages of 18 and 75 years old
  • A clinical diagnosis of cervical dystonia
  • On stable medications for 3 months

You will be excluded from the study if:

  • You have traumatic or tardive torticollis
  • You have predominant retrocollis or anterocollis
  • Hypersensitivity to botulinum toxin type A

This is a partial list of inclusion and exclusion criteria.

Study Details

Clinical Trial Investigator

Katie Kompoliti, MD

Contact Information

Olga Solonowicz

Clinical Trial Location

Rush University Medical Center
Rush Copley Medical Center

Locations

Rush University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Rush Copley Medical Center

2000 Ogden Ave
Aurora, IL 60504

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more